In these cases, the decrease in IRF4 level was probably caused by a decreased NF‐kB activity induced by CD86 or CD28, as both molecules can activate this signaling pathway in MM cells,76 an important regulator of IRF4 expression77 (Figure 4). The gene discussed is NFKB1; the disease is Miyoshi myopathy.